Antigen-related resistance |
-
■
Reduced HER2/NECTIN 4 levels
-
■
Tumor heterogeneity
-
■
Truncated forms of antigen ectodomain
-
■
Parallel genomic alteration
-
■
Heregulin
|
-
■
Bystander effect
-
■
Biparatropic ADC
|
Payload-related resistance |
-
■
DAR
-
■
Payload conjugation
|
-
■
Payload diversification: replacement of payload (auristatin vs. anthracycline based, topoisomerase I vs. belotecan derivative)
-
■
Lysine vs. cysteine conjugate
|
Altered internalization |
|
|
Impaired lysosomal function |
|
|
Overexpression of drug-efflux pumps |
|
|
Activation of signaling pathways |
|
|